Diarrhea and Constipation Both diarrhea and constipation are frequent side effects of GLP-1 medications
Baseline laboratory evaluation should include a complete blood count with differential, comprehensive metabolic panel, hepatic function tests, and tumor markers selected according to the patients demographics, family history, and clinical context
Nanotechnology in prostate diseases offers the unique advantages of enhanced targeting, improved drug solubility, and controlled drug release, which enhance therapeutic efficacy while minimizing side effects
Patients should understand that even after symptoms or effects diminish, measurable drug levels may persist for several weeks depending on the specific formulation used
After treatment with CPP-CAND, a significant reduction of approximately 7.1-fold in the number of FOXO4 foci was observed in the nuclei of the senescent cells